AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
24.07.25
/
50%
€23.00
Target price
24.07.26
€67.94
Performance (%)
73.04%
Price
27.01.26
€41.00
Summary
This prediction is currently active. With a performance of 73.04% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 24.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 4.061% | 4.061% |
| iShares Core DAX® | 0.170% | 2.184% |
| iShares Nasdaq 100 | 0.515% | 0.370% |
| iShares Nikkei 225® | 1.614% | 6.357% |
| iShares S&P 500 | -0.719% | -0.275% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat